Onconetix, Inc. (ONCO)
ONCO moved a median of -1.40% 30 minutes after news, and -1.67% by the close. How ONCO actually reacts to news — the realized, point-in-time move the market made, measured across 226 labeled events over the last three years with zero look-ahead.
ONCO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.48% | 38% | 216 |
| 30-min | -1.40% | 36% | 225 |
| 60-min | -2.15% | 34% | 226 |
| to close | -1.67% | 39% | 226 |
| Middle 50% of ONCO reactions | -4.42% to +1.21% |
|---|---|
| Median reaction (30-min) | -1.40% |
| Measured reactions | 226 |
Half of all Onconetix, Inc. news events land between -4.42% and +1.21% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ONCO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ONCO's baseline. Nothing else.
Recent ONCO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Form ARS Onconetix, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +1.38% | -8.24% | |
| Form DEF 14A Onconetix, Inc. For: Nov 10 | SEC filing · Form DEF | SEC EDGAR | -0.64% | -8.81% | |
| Form PRE 14A Onconetix, Inc. For: Sep 17 | SEC filing · Form PRE | SEC EDGAR | +0.01% | +0.76% | |
| CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition | Press release | GlobeNewswire | -1.55% | -3.16% | |
| Form 8-K Onconetix, Inc. For: Sep 11 | SEC filing · Form 8-K | SEC EDGAR | -1.67% | -8.93% | |
| Form DEFA14A Onconetix, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | — | -7.38% | |
| Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition | Press release | GlobeNewswire | +1.85% | -16.56% | |
| Form EFFECT Onconetix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -2.26% | +38.12% | |
| Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events | Press release | GlobeNewswire | +0.00% | +8.39% | |
| Form S-1/A Onconetix, Inc. | SEC filing · Form S-1 | SEC EDGAR | +0.00% | +5.43% | |
| Form 10-Q Onconetix, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +1.16% | -5.66% | |
| Form S-1 Onconetix, Inc. | SEC filing · Form S-1 | SEC EDGAR | — | -2.18% | |
| Onconetix Acquisition Target Realbotix Secures Agreement for Humanoid Robot Appearance on Emmy Award-Winning Streaming Series | Press release | GlobeNewswire | -8.46% | -7.56% | |
| Onconetix Announces Appointment of Ralph Schiess, PhD to Board of Directors of Proteomedix AG | Press release | GlobeNewswire | -0.61% | +22.56% | |
| Form 8-K Onconetix, Inc. For: Jul 28 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +12.33% | |
| Onconetix Highlights Realbotix Partnership with Bloom Services to Launch UK Pilot Using Humanoid Robots to Combat Elderly Social Isolation | Press release | GlobeNewswire | +1.30% | +1.91% | |
| Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District | Press release | GlobeNewswire | -3.96% | -0.99% | |
| Form EFFECT Onconetix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -2.39% | -2.46% | |
| Form S-1 Onconetix, Inc. | SEC filing · Form S-1 | SEC EDGAR | -2.03% | -3.38% | |
| Form 8-K Onconetix, Inc. For: May 19 | SEC filing · Form 8-K | SEC EDGAR | -7.89% | -4.68% | |
| Onconetix, Inc. Announces 1-for-10 Reverse Stock Split | Press release | GlobeNewswire | -5.56% | -37.83% | |
| Realbotix Provides Update on Nasdaq Listing | Press release | Business Wire | -5.56% | -37.83% | |
| Form 8-K Onconetix, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | -6.15% | -4.39% | |
| Form 10-Q Onconetix, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -4.37% | -5.10% | |
| Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study | Press release | GlobeNewswire | -4.37% | -5.10% | |
| Form EFFECT Onconetix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +1.23% | +1.95% | |
| Form EFFECT Onconetix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -2.65% | -3.92% | |
| Form POS AM Onconetix, Inc. | SEC filing · Form POS | SEC EDGAR | -3.64% | -10.22% | |
| Form S-1/A Onconetix, Inc. | SEC filing · Form S-1 | SEC EDGAR | -1.87% | +3.59% | |
| Form 8-K Onconetix, Inc. For: Apr 30 | SEC filing · Form 8-K | SEC EDGAR | -4.22% | -10.35% | |
| Form S-1 Onconetix, Inc. | SEC filing · Form S-1 | SEC EDGAR | +2.00% | +5.51% | |
| Form 8-K Onconetix, Inc. For: Apr 20 | SEC filing · Form 8-K | SEC EDGAR | -5.21% | -6.53% | |
| Onconetix Highlights Realbotix's Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson | Press release | GlobeNewswire | +6.48% | -24.69% | |
| Onconetix Highlights Realbotix AI Humanoid Robot Delivery Update | Press release | GlobeNewswire | +0.01% | -5.00% | |
| Onconetix Appoints David White as Chief Executive Officer and Sammy Dorf as Member of the Board of Directors | Press release | GlobeNewswire | -4.19% | -3.87% | |
| Form DEF 14A Onconetix, Inc. For: Apr 30 | SEC filing · Form DEF | SEC EDGAR | -6.35% | +6.80% | |
| Form 8-K Onconetix, Inc. For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | -2.58% | -66.61% | |
| Form 8-K/A Onconetix, Inc. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | -4.58% | +5.23% | |
| Onconetix Highlights Realbotix’s Role in Ericsson’s World-First 6G Trial Demonstration | Press release | GlobeNewswire | -1.44% | +2.94% | |
| Form 8-K Onconetix, Inc. For: Mar 18 | SEC filing · Form 8-K | SEC EDGAR | +2.04% | +2.71% | |
| Onconetix, Inc. Announces 1-for-5 Reverse Stock Split | Press release | GlobeNewswire | +2.83% | +11.49% | |
| Form PRE 14A Onconetix, Inc. For: Apr 30 | SEC filing · Form PRE | SEC EDGAR | -1.83% | -2.15% | |
| Form 10-K Onconetix, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -1.45% | -12.30% | |
| Form 8-K Onconetix, Inc. For: Feb 11 | SEC filing · Form 8-K | SEC EDGAR | -4.00% | -15.20% | |
| Onconetix to Acquire Realbotix LLC, USA-based, AI-Powered Humanoid Robotics Company | Press release | GlobeNewswire | -4.00% | -15.20% | |
| Realbotix Corp. Announces the Sale of Realbotix, LLC Subsidiary to a NASDAQ Listed Issuer | Press release | Business Wire | -4.00% | -15.20% | |
| Form 8-K Onconetix, Inc. For: Feb 03 | SEC filing · Form 8-K | SEC EDGAR | +3.36% | +26.89% | |
| Form DEF 14A Onconetix, Inc. For: Feb 03 | SEC filing · Form DEF | SEC EDGAR | +4.10% | -1.88% | |
| Form EFFECT Onconetix, Inc. | SEC filing · Form EFFECT | SEC EDGAR | -4.03% | -3.36% | |
| Form PRE 14A Onconetix, Inc. For: Dec 22 | SEC filing · Form PRE | SEC EDGAR | +0.00% | +0.00% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ONCO section they belong to.
Where else ONCO is measured.
ONCO earnings → · Analyst actions → · SEC filings →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Onconetix, Inc.'s median reaction calculated?
Every labeled ONCO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 226 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 36% of ONCO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ONCO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.